R&D | April 13, 2026
Merck India, MAHE launch catalyst program to build future R&D talent pipeline
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
The reports will now be shared with relevant ministries and departments as a guidance framework
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
Subscribe To Our Newsletter & Stay Updated
